Physician profile
Jonathan A Levy
NPI 1952644718
$9,332.54
in general payments reported to CMS, 2019-2025
28 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,518 · 2020: $206 · 2021: $1,612 · 2022: $2,973 · 2023: $819 · 2024: $2,097 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,750 · Food and Beverage: $999 · Travel and Lodging: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,750.00 |
| Food and Beverage | $999.46 |
| Travel and Lodging | $274.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,778.26 | 2021-2023 | Da Vinci Sp |
| Stryker Corporation | $1,787.19 | 2023-2024 | Spy-Phi System |
| Ethicon US, LLC | $998.98 | 2019-2025 | Echelon Circular, Echelon; Endopath, Linx Reflux Management System |
| Boston Scientific Corporation | $627.90 | 2019-2022 | |
| Medical Device Business Services, INC. | $594.94 | 2019 | |
| Journey Medical Corporation | $242.59 | 2021-2022 | |
| Davol INC. | $232.79 | 2023-2024 | Bard 3dmax Mesh, Arista Ah Flexitip, Phasix Mesh |
| W. L. Gore & Associates, INC. | $180.33 | 2021-2024 | Gore Enform Preperitoneal Biomaterial |
| Medtronic, INC. | $130.88 | 2023-2025 | Accuvac, Transorb |
| Endogastric Solutions, INC | $112.00 | 2021 | |
| Smith+Nephew, INC. | $111.48 | 2020-2022 | |
| Conmed Corporation | $77.25 | 2024 | Airseal |
| Pinnacle Biologics, INC | $74.50 | 2022 | |
| Kerecis Limited | $47.03 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Abbvie INC. | $45.47 | 2023-2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $44.56 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Polynovo North America LLC | $44.16 | 2024 | Novosorb Btm |
| Fx Shoulder Solutions, INC | $33.18 | 2021 | |
| Heron Therapeutics, INC. | $32.92 | 2021-2023 | Zynrelef |
| Dynasplint Systems INC. | $26.09 | 2025 | Dynasplint |
| Braintree Laboratories, INC. | $25.25 | 2023 | Sutab, Suflave |
| E.R. Squibb & Sons, L.L.C. | $22.86 | 2019 | |
| Mentor Worldwide LLC | $19.94 | 2022 | |
| Convatec INC. | $16.92 | 2021 | |
| Lucid Diagnostics INC. | $13.71 | 2023 | |
| Acell, INC. | $11.36 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.